A detailed history of Concord Wealth Partners transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Concord Wealth Partners holds 275 shares of LH stock, worth $55,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares
275
Previous 183 50.27%
Holding current value
$55,750
Previous $41,000 46.34%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$209.01 - $232.56 $19,228 - $21,395
92 Added 50.27%
275 $60,000
Q4 2023

Apr 30, 2024

SELL
$197.69 - $227.29 $37,363 - $42,957
-189 Reduced 50.81%
183 $41,000
Q4 2023

Feb 05, 2024

SELL
$197.69 - $227.29 $37,363 - $42,957
-189 Reduced 50.81%
183 $41,000
Q3 2023

Apr 30, 2024

BUY
$201.05 - $221.7 $37,998 - $41,901
189 Added 103.28%
372 $74,000
Q3 2023

Oct 25, 2023

SELL
$201.05 - $221.7 $4,825 - $5,320
-24 Reduced 6.06%
372 $74,000
Q2 2023

Aug 07, 2023

BUY
$211.93 - $241.33 $19,497 - $22,202
92 Added 30.26%
396 $95,000
Q1 2023

Apr 26, 2023

SELL
$213.32 - $257.83 $21,758 - $26,298
-102 Reduced 25.12%
304 $69,000
Q4 2022

Jan 27, 2023

BUY
$203.72 - $248.97 $82,710 - $101,081
406 New
406 $95,000
Q2 2022

Aug 04, 2022

SELL
$213.86 - $277.87 $78,700 - $102,256
-368 Reduced 49.07%
382 $90,000
Q1 2022

Apr 20, 2022

SELL
$259.82 - $298.18 $4,157 - $4,770
-16 Reduced 2.09%
750 $198,000
Q4 2021

Jan 21, 2022

BUY
$271.6 - $314.21 $28,246 - $32,677
104 Added 15.71%
766 $241,000
Q3 2021

Nov 09, 2021

SELL
$274.82 - $308.34 $92,889 - $104,218
-338 Reduced 33.8%
662 $186,000
Q2 2021

Jul 29, 2021

SELL
$251.87 - $278.14 $16,623 - $18,357
-66 Reduced 6.19%
1,000 $276,000
Q1 2021

May 13, 2021

BUY
$204.88 - $255.03 $2,048 - $2,550
10 Added 0.95%
1,066 $272,000
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $197,376 - $226,427
1,056 New
1,056 $215,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.